磺达肝素
直接凝血酶抑制剂的发现与发展
医学
肝素
重症监护医学
模式
直接凝血酶抑制剂
药理学
凝血酶
静脉血栓栓塞
达比加群
内科学
血栓形成
华法林
心房颤动
社会学
社会科学
血小板
作者
Scott T. Avecilla,Mikhail Roshal,Morayma Reyes Gil,Patrick A. Erdman
出处
期刊:Elsevier eBooks
[Elsevier]
日期:2019-01-01
卷期号:: 933-938
被引量:1
标识
DOI:10.1016/b978-0-12-813726-0.00159-8
摘要
Laboratory testing modalities and recommendations for monitoring heparin, heparin-like medications, direct thrombin inhibitors (DTIs), and direct anti-Xa inhibitors (DXIs), including indications, testing recommendations, testing modalities, and test limitations are discussed. There are several options available for laboratory monitoring of these drugs, all with varying levels of utility. New DTI's and DXI's are in clinical trials and the number of patients undergoing direct oral anticoagulant therapy will continue to expand.
科研通智能强力驱动
Strongly Powered by AbleSci AI